NCT Number: NCT05915442
Phase: PHASE2
Trial Summary: This study will evaluate the safety and effectiveness of a combination of study drugs including zimberelimab, etrumadenant, and quemliclustat in combination with metastasis-directed irradiation in men – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Catherine Spina
Acronym: SBRT-AMICO
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives